Biotech

- Advertisement -
Ad imageAd image
Takeda Commits Over $1.7 Billion to AI-Driven Drug Discovery in Major Partnership with Iambic

One of Japan's largest pharmaceutical companies, Takeda Pharmaceutical Company, has ramped up the use of AI in drug research through a multi, year partnership with AI biotech, Iambic Therapeutics, whose…

UK and Japan Forge Strategic Biotech Alliance to Propel Innovation

The UK BioIndustry Association (BIA) is joining forces with the Japan Bioindustry…

Celaid Therapeutics Raises ¥1.05B for Stem Cell Growth

Celaid Therapeutics Inc. announced that it successfully completed the first close of…

Hinge Bio partners with Kyorin to Develop HB2198 in Japan

Hinge Bio, Inc., a private biotech firm that focuses on multispecific antibody…

Celaid Therapeutics and AGC sign iPSC-HSPC research deal

Celaid Therapeutics Inc. Celaid has teamed up with AGC Inc. for a…

Asahi Kasei Opens New Plant to Boost Planova Output

Asahi Kasei Life Science will build a new spinning plant in Nobeoka…

Pahr Therapeutics secures $14M to develop PAH therapies

Pahr Therapeutics has raised $14 million in seed funding. This money will…

Alloy Therapeutics, KSAC team up to grow Japan Biotechs

Alloy Therapeutics Co. Ltd. (Alloy Japan) signed a Memorandum of Understanding (MOU)…

NKGen and HekaBio team up on NK Cell therapy in Japan

NKGen Biotech, Inc. is a clinical-stage biotech firm. They focus on NK…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community